Massachusetts Financial Services
PCRX icon

Massachusetts Financial Services’s Pacira BioSciences PCRX Stock Holding History

Massachusetts Financial Services’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$791K Buy
+31,178
New +$737K ﹤0.01% 908
2024
Q4 		– Sell
-14,419
Closed -$217K – 916
2024
Q3 		$217K Buy
+14,419
New +$247K ﹤0.01% 840

Other funds holding PCRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $431M AUM 13.21% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Massachusetts Financial Services's PCRX Position: Q2 2026 in Review

Massachusetts Financial Services opened a new position in Pacira BioSciences (PCRX) in Q2 2026: 31,178 shares worth $791K. The stake represents ﹤0.01% of the portfolio and ranks #908 among its holdings. This is a return to the name: Massachusetts Financial Services previously reported a position in PCRX as recently as Q3 2024.

Massachusetts Financial Services first reported a position in PCRX in Q3 2024 and has held it in 2 quarters since. 254 funds tracked by Wall St. Rank hold PCRX as of Q2 2026.

  • Massachusetts Financial Services held 31,178 shares of Pacira BioSciences worth $791K as of Q2 2026.
  • Pacira BioSciences was a new Massachusetts Financial Services position in Q2 2026.
  • Pacira BioSciences made up ﹤0.01% of Massachusetts Financial Services's portfolio in Q2 2026, its #908 holding.
  • Massachusetts Financial Services first reported a position in Pacira BioSciences in Q3 2024 and has held it in 2 quarters since.
  • 254 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2026.

Based on Massachusetts Financial Services's 13F filing for Q2 2026, filed 3 Aug 2026.